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http://dx.doi.org/10.1016/j.gmbhs.20Abstract In our previous study, we developed the great burdock essence compounds success-
fully. Clinical trial has proved that great burdock can function as an adjuvant therapy for pa-
tients with gastric ulcer caused by Helicobacter pylori. This study aims to assess the storage
stability of great burdock essence compounds. We used the high-performance liquid chroma-
tography method to test the concentration of chlorogenic acids at different times in the long-
term storage test and accelerated storage test, and observed their appearance. The results
showed that the concentration of chlorogenic acids degraded from 29.29  0.49 mg/g to
28.29  0.40 mg/g during the accelerated storage tests conducted for up to 6 months. In addi-
tion, the concentration of chlorogenic acids degraded from 29.29  0.49 mg/g to
28.57  0.21 mg/g during the long-term storage tests conducted for a period of up to 12
months. In both these tests, no change was observed in trait, scent, and color of the great
burdock essence compounds. These results suggest that these compounds are highly stable.
Copyright ª 2013, Taiwan Genomic Medicine and Biomarker Society. Published by Elsevier
Taiwan LLC. All rights reserved.Introduction
Arctium lappa, Linn belong to the Asteraceae family and
contains nutrients such as inulin, crude fiber, protein,f Medical Research, Fooyin
shan Road, Donggang Town-
t (S.-R. Lin).
to this work.
an Genomic Medicine and Bioma
13.04.002calcium, phosphorus, iron, and multiple essential vitamins
and minerals. The polyphenolic content of great burdock is
primarily made up of chlorogenic acids; studies have shown
that it has antioxidant properties, can prevent iron-induced
radical formation effectively, and possesses antimicrobial,
anti-inflammatory, analgesic, and antipyretic activities.1e4
Previous studies have indicated that great burdock pos-
sesses antimicrobial activity, provides gastric mucosal and
liver protection, and has anti-inflammatory and anticancer
effects.5e10 Arnebia euchroma is a member of therker Society. Published by Elsevier Taiwan LLC. All rights reserved.
Figure 1 Color of great burdock essence compounds was
observed visually by pouring the compounds from a brown glass
bottle into a 15-mL tube.
68 M.-K. Ku et al.Boraginaceae family, and its main nutrients are naph-
thoquinone derivatives. The use of A. euchroma in Chinese
medicine is well established. Ingestion of A. euchroma has
been documented to provide antipyretic and detoxification
effects, reduce swelling, and improve bowel movements.
External applications of A. euchroma are used for treating
macula, smallpox, burns, dermatitis, and eczema. It has been
validated in the studies of Chinese medicine pharmacology
that A. euchroma can accelerate granulation tissue prolifer-
ation, and shows anti-inflammatory, antibacterial, and anti-
tumor activities.11e16 Angelica sinensis is an Umbelliferae
plant; its chemical composition includes primarily volatile
oils, andwater-soluble alkaloids andorganicacids, alongwith
ferulic acid as themain active ingredient. It is conventionally
used in the treatment of gynecological diseases and ane-
mia.17 In recent studies,A. sinensishasbeen shown topossess
immune system modulation, antioxidation, anti-
inflammatory, and anticancer properties.18e20
The great burdock essence compounds are formulated
using a nanomicell, which is similar to liposome in structure.
A liposome is a dual-layered, self-closing, spherical particleTable 1 Results of the accelerated storage tests of great burdo
Assessment criteria 0 mo 1 mo
Trait Viscous solution Viscous solution Viscous so
Scent Mild sesame
oil scent
Mild sesame
oil scent
Mild sesam
oil scent
Color Tawny Tawny Tawny
Chlorogenic
acid (mg/g)
(N Z 3)
27e33 29.29  0.49 29.31  0
The values of chlorogenic acid are expressed as meanþSD; SD Z stanthat contains a single (or multiple) lipid bilayer(s) sur-
rounding an aqueous solution. Liposomes are vectors capable
of embedding hydrophobic substances in their lipid bilayer
and enclosing hydrophilic substances in their aqueous phase.
The great burdock essence compounds contain a lipid phase,
an emulsifier, and a small amount of aqueous phase. The lipid
phase carries the main ingredients of A. euchroma and A.
sinensis, which are also the main ingredients of great
burdock. The lipid phase is enclosed by lecithin, and the
outer layer is further covered with an aqueous layer. The
resulting particle offers the following advantages: they show
good stability and high hydrophilicity, are free of irritants
and ethanol, exhibit improved absorbance of active in-
gredients, and are bioavailable. After ingestion, the particle
makes contact with water and disintegrates into micro-
emulsions, approximately 100 nm in size, to cover the gastric
mucosa. The nanomicell is absorbed easily because of its
structural similarity with the cell membrane.
An investigation into the effect of great burdock essence
compounds on Helicobacter pylori infection showed that
the great burdock essence compounds could help suppress
H. pylori growth in infected patients.21
A stability test is a critical evaluation and an important
basis for the quality of nutraceutical preservation. The
primary goal of the current study was to determine the
temporal impact of environmental factors (temperature,
humidity, and light) on nutraceuticals. Subsequently, the
shelf life of great burdock essence compounds was calcu-
lated for providing quality assurance of the product.
Materials and methods
Production and preparation of samples
The samples of great burdock essence compounds were
assigned to a good manufacturing practice (GMP)-certified
factory to produce three batches, which were then pack-
aged in sealed glass bottles of 10 mL capacity after going
through the pasteurization process. The three batches un-
derwent the storage test, trait analysis, and high-
performance liquid chromatography (HPLC) analysis.
Storage test and sample collection time points
The long-term storage test was conducted at a storage
temperature of 25  2C and a humidity of 60  5%.ck essence compounds.
2 mo 3 mo 6 mo
lution Viscous solution Viscous solution Viscous solution
e Mild sesame
oil scent
Mild sesame
oil scent
Mild sesame
oil scent
Tawny Tawny Tawny
.46 29.09  0.26 28.73  0.37 28.29  0.40
dard deviation.
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Figure 2 Chlorogenic acid degradation curve of great
burdock essence compounds for accelerated storage tests.
Shelf life of great burdock essence compounds 69Sampling time points were at 0 months, 3 months, 6
months, 9 months, 12 months, 18 months, 24 months, and
36 months. In the accelerated storage test, the storage
temperature was 40  2C and the humidity was 75  5%.
Samples were collected at 0 month, 1 month, 2 month, 3
month, and 6 month time points.
Trait analysis
Traits and color of the great burdock essence compounds
were visually observed and recorded, along with their
smell. The color of great burdock essence compounds is
tawny (Fig. 1).
HPLC analysis
HPLC separation was performed at room temperature using
a Hewlett Packard 1100 liquid chromatography system with
a DAD G1315A detector (Hewlett Packard, Palo Alto, CA,
USA). Analysis was performed using a Vercopak Inertsil 5
ODS (250e4.6 mm) column (GL Sciences, Inc., USA). A
constant flow rate of 1 mL/min was employed and the
eluent was monitored at 245 nm by the DAD detector. The
following steps were carried out: (1) preparation of the
chlorogenic acid standard. A total of 10.5 g of chlorogenic
acid standard (FLUKA, Cat. No. 00500590) was dissolved in
50% methanol to a final concentration of 26.25 mg/mL
(namely the 400 solution); (2) preparation of the great
burdock essence compounds. Great burdock essence com-
pounds (5 g) were added to 10 mL of methanol. The mixtureTable 2 Results of the long-term storage tests of great burdoc
Assessment criteria 0 mo 3 mo
Trait Viscous solution Viscous solution Viscous so
Scent Mild sesame
oil scent
Mild sesame
oil scent
Mild sesam
oil scent
Color Tawny Tawny Tawny
Chlorogenic
acid (mg/g)
(N Z 3)
27e33 29.29  0.49 29.45  0
The values of chlorogenic acid are expressed as meanþSD; SD Z stanwas subjected to vigorous agitation to ensure proper mix-
ing, and subsequently centrifuged for 10 minutes. The su-
pernatant was collected and filtered through a 0.45 mm
membrane filter; (3) the mobile phase consisted of (A)
methanol, water, and acetic acid (15:83:2, v/v) and (B)
methanol, water, and acetic acid (70:28:2, v/v). The
elution profile was as follows: 0e30 minutes, the mobile
phase consisted of 100% A; 30e31 minutes, A decreased to
0% and B increased to 100%; 31e45 minutes, it consisted of
100% B; 45e46 minutes, B decreased to 0% and A increased
to 100%; and 46e55 minutes, it consisted of 100% A. The
HPLC column was run at a flow rate of 1.0 mL/min; and (4)
HPLC protocol. Standard solution (10 mL) and the prepared
great burdock essence compounds were injected separately
into the chromatography apparatus. The chromatograms
were recorded and the major peak values were
determined.
Results
Result of the accelerated storage test
The traits of samples stored for 0 months, 1 month, 2
months, 3 months, and 6 months all presented viscous solu-
tions tawny in color and released amild aroma of sesame oil.
The chlorogenic acid content measured for the 0 months, 1
month, 2 month, 3 month, and 6 month samples were
29.29  0.49 mg/g, 29.31  0.46 mg/g, 29.09  0.26 mg/g,
28.73  0.37 mg/g, and 28.29  0.40 mg/g, respectively
(Table 1). A comparison of the average concentration of
chlorogenic acids in 1 month, 2 months, 3 months, and 6
months with that in the 0th month showed that chlorogenic
acid content reduced from 100% to 96.56% during the
sequence of tests covering up to 6 months (Fig. 2).
Result of the long-term storage test
Samples collected at 0 months, 3 months, 6 months, 9
months, 12 months, and 18 months all presented traits of
viscous solutions tawny in color and gave off a mild scent of
sesame oil. The chlorogenic acid content measured for the
0 month, 3 month, 6 month, 9 month, and 12 month sam-
ples were 29.29  0.49 mg/g, 29.45  0.51 mg/g,
28.81  0.55 mg/g, 28.20  0.14 mg/g, and,
28.57  0.21 mg/g, respectively (Table 2). A comparison of
the average concentration of chlorogenic acids in 3 months,k essence compounds.
6 mo 9 mo 12 mo
lution Viscous solution Viscous solution Viscous solution
e Mild sesame
oil scent
Mild sesame
oil scent
Mild sesame
oil scent
Tawny Tawny Tawny
.51 28.81  0.55 28.20  0.14 28.57  0.21
dard deviation.
110
100
90
80
0 3 6 9 12 Month
%
 C
hl
or
og
en
ic 
ac
id
 c
on
te
nt
Figure 3 Chlorogenic acid degradation curve of great
burdock essence compounds for long-term storage tests.
70 M.-K. Ku et al.6 months, 9 months, and 12 months with that in the 0th
month showing that chlorogenic acid content reduced from
100% to 97.52% during the sequence of tests conducted over
a period of up to 12 months (Fig. 3).
Discussion
The results showed that chlorogenic acid content reduced
from 100% to 97.52% during long-term storage tests span-
ning a period of up to 12 months and reduced from 100% to
96.52% during accelerated storage tests covering up to 6
months. These results suggest that the chlorogenic acid
content of the great burdock essence compounds is highly
stable. The product shelf life could be extrapolated from
the long-term storage test results. Firstly, the feasibility of
time-dependent product degradation curve needs to be
assessed by the goodness-of-fit test. Extrapolation of the
nutraceutical shelf life is then achieved by determining the
intersection between the lower bound of the 95% confi-
dence interval of product degradation curve and the
specified limit (such as 90% of the labeled content). Finally,
the product shelf life is estimated by rounding off the nu-
traceutical shelf life to the nearest year or half-year (such
as rounding off 25 months to 2 years). In the current study,
the lower bound of the 95% confidence interval of the
degradation curve at 12 months was valued at 92.64%,
which is yet to intersect with the specified limit of 90% of
the labeled content. Therefore, the shelf life of great
burdock essence compounds exceeds 12 months. However,
determination of a definite shelf life requires further
evaluation of the 18 month, 24 month, and 36 month
samples.
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